Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
Precise™ MRD
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Myriad Genetics
Type:
Laboratory Developed Test
Related tests:
‹
BRACAnalysis CDx™ (28)
Myriad myChoice® CDx (19)
COLARIS AP®
COLARIS®
Counsyl Reliant™ Cancer Screen
Myriad myChoice® CDx Plus
Myriad myRisk® Hereditary Cancer
PANEXIA™
Precise™ Liquid
Precise™ Tumor Molecular Profile Test
Prolaris®
myPath Melanoma
BRACAnalysis CDx™ (28)
Myriad myChoice® CDx (19)
COLARIS AP®
COLARIS®
Counsyl Reliant™ Cancer Screen
Myriad myChoice® CDx Plus
Myriad myRisk® Hereditary Cancer
PANEXIA™
Precise™ Liquid
Precise™ Tumor Molecular Profile Test
Prolaris®
myPath Melanoma
›
Details
Evidence
News
Monitoring test based on whole genome sequencing to deeply interrogate tumor and detect recurrence earlier and help guide treatment decisions.
Method:
Whole genome sequencing
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.